Neurotron

Neurotron is an established medical technology company specializing in the development of electrodiagnostic sensory nerve testing equipment, most notably the Neurometer CPT. The company's proprietary technology utilizes quantitative sensory testing (QST) to painlessly measure the Current Perception Threshold (CPT) across distinct sensory nerve fiber types, including large myelinated (Aβ), small myelinated (Aδ), and unmyelinated (C) fibers. This objective approach allows for the early detection and quantification of sensory impairments such as hyperesthesia and hypoesthesia, aiding in the diagnosis of neuropathies related to diabetes, localized nerve injury, and toxicity. Widely utilized in clinical practice and pharmaceutical research, Neurotron's devices serve as a critical tool for monitoring disease progression and evaluating the neuro-efficacy of therapeutic interventions.